Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UNIVERSIDADE DO ALGARVE has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This involves 1 distinct examiner and 1 distinct art unit. SALMON, KATHERINE D is the busiest examiner, with 1 busiest examiner pending action. The current prosecution activity is concentrated under 1 distinct examiner and within 1 distinct art unit.
This concentration in the Biotechnology & Pharmaceuticals sector indicates a narrow technical focus for the university's current 1 pending office action. Having 1 distinct examiner, SALMON, KATHERINE D, allows for a consistent and targeted prosecution approach. The 1 pending office action represents the total active workload for this entity at the moment. With only 1 distinct art unit involved, the subject matter is likely confined to a specific technical classification. The fact that SALMON, KATHERINE D holds 1 busiest examiner pending action confirms that there are no other examiners currently reviewing pending actions for the university. This streamlined profile makes it easier to manage the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 1 | 42.8% | +37.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18460549 | METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF | SALMON, KATHERINE D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18460549 | METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF | SALMON, KATHERINE D | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18460549 | METHODS OF ANALYSIS OF ALLELIC EXPRESSION OF PIK3CA IN CANCER AND USES THEREOF | SALMON, KATHERINE D | 1682 | §101§103§112 | Non-Final OA | — | Pending | Sep 03, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial